Cargando…

Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits

Alzheimer’s disease (AD) is a neurodegenerative condition that leads to neuronal death and memory dysfunction. In the past, specific peroxisome proliferator-activated receptor (PPAR)γ-agonists, such as pioglitazone, have been tested with limited success to improve AD pathology. Here, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kummer, Markus P., Schwarzenberger, Rafael, Sayah-Jeanne, Sakina, Dubernet, Mathieu, Walczak, Robert, Hum, Dean W., Schwartz, Stephanie, Axt, Daisy, Heneka, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359287/ https://www.ncbi.nlm.nih.gov/pubmed/24838579 http://dx.doi.org/10.1007/s12035-014-8743-4

Ejemplares similares

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

PPARs in Alzheimer's Disease
por: Kummer, Markus P., et al.
Publicado: (2008)

SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice
por: Wu, Qiong, et al.
Publicado: (2020)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice
por: Song, Min, et al.
Publicado: (2012)

Truncated and modified amyloid-beta species
por: Kummer, Markus P, et al.
Publicado: (2014)

Impact and Therapeutic Potential of PPARs in Alzheimer's Disease
por: Heneka, Michael T, et al.
Publicado: (2011)

Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease
por: Leparulo, Alessandro, et al.
Publicado: (2019)

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
por: Heneka, Michael T, et al.
Publicado: (2005)

Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide
por: Zhang, Jian-Xiang, et al.
Publicado: (2019)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
por: Button, Emily B., et al.
Publicado: (2019)

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
por: Killick, Richard, et al.
Publicado: (2009)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
por: Weekman, Erica M, et al.
Publicado: (2014)

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice
por: Li, Bin, et al.
Publicado: (2011)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
por: Dickey, Chad A, et al.
Publicado: (2005)

EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques
por: Kim, Hye Yun, et al.
Publicado: (2015)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
por: Espinoza, Sandra, et al.
Publicado: (2022)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
por: Luo, Gang, et al.
Publicado: (2016)

Corrigendum: EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques
por: Kim, Hye Yun, et al.
Publicado: (2016)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
por: Geng, Pengcheng, et al.
Publicado: (2018)

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
por: Reale, Marcella, et al.
Publicado: (2018)

Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice
por: Wang, Zehao, et al.
Publicado: (2023)

Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice
por: Qiu, Hui, et al.
Publicado: (2022)

Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice
por: Li, Zongyang, et al.
Publicado: (2022)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides(i)
por: Fleisher-Berkovich, Sigal, et al.
Publicado: (2010)

Navβ2 knockdown improves cognition in APP/PS1 mice by partially inhibiting seizures and APP amyloid processing
por: Hu, Tao, et al.
Publicado: (2017)

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
por: Wilcock, Donna M, et al.
Publicado: (2004)

Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012)

The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
por: Forest, Kelly H., et al.
Publicado: (2021)

Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice
por: Tian, Tian, et al.
Publicado: (2016)

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP
por: Wiseman, Frances K, et al.
Publicado: (2018)

Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators
por: Adeghate, Ernest, et al.
Publicado: (2011)

Metabolomics dataset of PPAR-pan treated rat liver
por: Ament, Zsuzsanna, et al.
Publicado: (2016)

Hyperoxygenation Treatment Reduces Beta-amyloid Deposition via MeCP2-dependent Upregulation of MMP-2 and MMP-9 in the Hippocampus of Tg-APP/PS1 Mice
por: Choi, Juli, et al.
Publicado: (2021)

Humulus lupulus L. Extract Protects against Senior Osteoporosis through Inhibiting Amyloid β Deposition and Oxidative Stress in APP/PS1 Mutated Transgenic Mice and Osteoblasts
por: Xia, Tianshuang, et al.
Publicado: (2023)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4cni92jstq0nebr5gcrnne2hbg